Abstract
An impressive variety of new methodologies for the preparation of 18F-labelled tracers and ligands has appeared over the last decade. Most strategies of the newly developed radiofluorination methods predominantly aim at products of high molar activity by ‘late-stage’ labelling of small (hetero)aromatic molecules and the use of transition metals. This is accompanied by the improvement of technical procedures, like preparation of reactive [18F]fluoride and automated syntheses. The newly introduced procedures reflect a high innovative level and creativity in radio(pharmaceutical) chemistry at present, which are based on modern chemical methods and deep mechanistic insights. Taking also automation and quality control into consideration, major recently developed radiofluorination methods, most of those still under development, are compiled here in view of their potential for clinical PET imaging and thus the ability to advance molecular imaging.
Similar content being viewed by others
References
Preshlock S, Tredwell M, Gouverneur V (2016) 18F-labeling of arenes and heteroarenes for applications in positron emission tomography. Chem Rev 116:719–766
Cole EL, Stewart MN, Littich R, Hoareau R, Scott PJH (2014) Radiosyntheses using fluorine-18: the art and science of late stage fluorination. Curr Top Med Chem 14:875–900
van der Born D, Pees A, Poot AJ, Orru RVA, Windhorst AD, Vugts DJ (2017) Fluorine-18 labelled building blocks for PET tracer synthesis. Chem Soc Rev 46:4709–4773
Schirrmacher R, Wängler B, Bailey J, Bernard-Gauthier V, Schirrmacher E, Wängler C (2017) Small prosthetic groups in 18F-radiochemistry: useful auxiliaries for the design of 18F-PET tracers. Semin Nucl Med 47:474–492
Kniess T, Laube M, Brust P, Steinbach J (2015) 2-[18F]Fluoroethyl tosylate—a versatile tool for building 18F-based radiotracers for positron emission tomography. Med Chem Commun 6:1714–1754
Buckingham F, Gouverneur V (2016) Asymmetric 18F-fluorination for applications in positron emission tomography. Chem Sci 7:1645–1652
Laverman P, McBride WJ, Sharkey RM, Goldenberg DM, Boerman OC (2014) Al18F labeling of peptides and proteins. J Label Compd Radiopharm 57:219–223
Burke BP, Clemente GS, Archibald SJ (2015) Boron-18F containing positron emission tomography radiotracers: advances and opportunities. Contrast Media Mol Imaging 10:96–110
Bernard-Gauthier V, Bailey JJ, Liu Z, Wängler B, Wängler C, Jurkschat K, Perrin DM, Schirrmacher R (2016) From unorthodox to established: the current status of 18F-trifluoroborate- and 18F-SiFA-based radiopharmaceuticals in PET nuclear imaging. Bioconjug Chem 27:267–279
Chansaenpak K, Wang M, Wang H, Giglio BC, Gabbai FP, Wu Z, Li Z (2017) Preparation of [18F]-NHC-BF3 conjugates and their applications in PET imaging. RSC Adv 7:17748–17751
Roeda D, Dolle F (2015) Recent developments in the chemistry of [18F]fluoride for PET. Chemistry of Molecular Imaging, ed. Long N, Wong W T. Hoboken: John Wiley & Sons Inc. 55-77
Jacobson O, Kiesewetter DO, Chen X (2015) Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjugate Chem 26:1–18
Wan WX, Guo N, Pan DH, Yu CJ, Weng Y, Luo SN, Ding H, Xu YP, Wang LZ, Lang LX, Xie QG, Yang M, Chen XY (2013) First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. J Nucl Med 54:691–698
Lien VT, Riss PJ (2014) Radiosynthesis of [18F]Trifluoroalkyl groups: scope and limitations. BioMed Res Int 2014:380124
Honer M, Gobbi L, Martarello L, Comley RA (2014) Radioligand development for molecular imaging of the central nervous system with positron emission tomography. Drug Discov Today 19:1936–1944
Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD (2017) Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight. Nucl Med Biol 55:v-xi
Firnau G, Chirakal R, Garnett ES (1984) Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-L-dopa. J Nucl Med 25:1228–1233
Ido T, Wan CN, Casella V, Fowler JS, Wolf AP, Reivich M, Kuhl DE (1978) Labeled 2-deoxy-d-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-d-glucose, 2-deoxy-2-fluoro-d-mannose and 14C-2-deoxy-2-fluoro-d-glucose. J Label Compd Radiopharm 14:175–183
Fowler JS, Ido T (2002) Initial and subsequent approach for the synthesis of 18FDG. Semin Nucl Med 32:6–12
de Vries EFJ, Luurtsema G, Brüssermann M, Elsinga PH, Vaalburg W (1999) Fully automated synthesis module for the high yield one-pot preparation of 6-[18F]fluoro-l-DOPA. Appl Rad Isot 51:389–394
Pretze M, Wängler C, Wängler B (2014) 6-[18F]fluoro-L-DOPA: A well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses. BioMed Res Int 2014
Antuganov DO, Zykov MP, Ryzhkova DV, Zykova TA, Vinal’ev AA, Antuganova YO, Samburov OP (2016) Synthesis of [18F]-L-DOPA radiopharmaceutical on a modified GE TracerLAB Fx F-E platform. Radiochemistry 58:649-653
Füchtner F, Zessin J, Mäding P, Wüst F (2008) Aspects of 6-[18F]fluoro-L-DOPA preparation: deuterochloroform as a substitute solvent for Freon 11. NuklearMedizin 47:62–64
Forsback S, Eskola O, Bergman J, Haaparanta M, Solin O (2009) Alternative solvents for electrophilic synthesis of 6-[18F]fluoro-L-DOPA. J Label Compd Radiopharm 52:286–288
Coenen HH (2007) Fluorine-18 Labeling Methods: Features and Possibilities of Basic Reactions In: Schubiger P A, Lehmann L, Friebe M (eds.) PET Chemistry: The Driving Force in Molecular Imaging. Ernst Schering Research Foundation Workshop 62. Springer, Heidelberg, pp 15–50
Miller PW, Long NJ, Vilar R, Gee AD (2008) Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Ang Chem Int Ed 47:8998–9033
Bergman J, Johnström P, Haaparanta M, Solin O, Duelfer T, Stone-Elander S (1995) Radiolabelling of 2-oxoquazepam with electrophilic 18F prepared from [18F]fluoride. Appl Rad Isot 46:1027–1034
Bergman J, Solin O (1997) Fluorine-18-labeled fluorine gas for synthesis of tracer molecules. Nucl Med Biol 24:677–683
Forsback S, Solin O (2015) Post-target produced [18F]F2 in the production of PET radiopharmaceuticals. Radiochim Acta 103:219–226
Krzyczmonik A, Keller T, Kirjavainen AK, Forsback S, Solin O (2017) Vacuum ultraviolet photon–mediated production of [18F]2. J Label Compd Radiopharm 60:186–193
Stenhagen ISR, Kirjavainen AK, Forsback SJ, Jørgensen CG, Robins EG, Luthra SK, Solin O, Gouverneur V (2013) Fluorination of an arylboronic ester using [18F]selectfluor bis(triflate): application to 6-[18F]fluoro-L-DOPA. Chem Commun 49:1386–1388
Kilbourn MR (1990) Fluorine-18 labeling of radiopharmaceuticals. Nuclear science series. National Academy Press, Washington, DC, p 149
Coenen HH (1986) New radiohalogenation methods: An overview. In: Cox PH et al (eds) Progress in radiopharmacy. Springer, Berlin, Heidelberg, pp 196–220
Guillaume M, Luxen A, Nebeling B, Argentini M, Clark JC, Pike VW (1991) Recommendations for fluorine-18 production. Int J Appl Radiat Isot 42:749–762
Stöcklin G, Qaim SM, Rösch F (1995) The impact of radioactivity on medicine. Radiochim Acta 70–1:249–272
Awasthi V, Watson J, Gali H, Matlock G, McFarland A, Bailey J, Anzellotti A (2014) A “dose on demand” Biomarker Generator for automated production of [18F]F− and [18F]FDG. Appl Rad Isot 89:167–175
Siikanen J, Ohlsson T, Medema J, Van-Essen J, Sandell A (2013) A niobium water target for routine production of [18F]Fluoride with a MC 17 cyclotron. Appl Rad Isot 72:133–136
Berridge MS, Voelker KW, Bennington B (2002) High-yield, low-pressure [18O]water targets of titanium and niobium for F-18 production on MC-17 cyclotrons. Appl Rad Isot 57:303–308
Satyamurthy N, Amarasekera B, Alvord CW, Barrio JR, Phelps ME (2002) Tantalum [18O]water target for the production of [18F]Fluoride with high reactivity for the preparation of 2-deoxy-2-[18F]Fluoro-d-glucose. Mol Imaging Biol 4:65–70
Gatley JS, Shaughnessy WJ (1982) Production of 18F-labeled compounds with 18F− produced with a 1-MW research reactor. Int J Appl Rad Isot 33:1325–1330
Coenen HH, Klatte B, Knöchel A (1986) Preparation of n.c.a. [17-18F]-fluoroheptadecanoic acid in high yields via aminopolyether supported, nucleophilic fluorination. J Label Compd Radiopharm 23:455–466
Hamacher K, Coenen HH, Stöcklin G (1986) Efficient stereospecific synthesis of no-carrier-added 2-[18F]fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235–238
De Ruysscher D, Haustermans K, Thorwarth D (2016) FDG and Beyond. In: Baumann M, Krause M, Cordes N (eds) Molecular radio-oncology. Springer, Berlin, Heidelberg, pp 163–173
Hamacher K, Blessing G, Nebeling B (1990) Computer-aided synthesis (CAS) of no-carrier-added 2-[18F]fluoro-2-deoxy-d-glucose: an efficient automated system for the aminopolyether-supported nucleophilic fluorination. Appl Rad Isot 41:49–55
Krasikova R (2007) Synthesis modules and automation in F-18 labeling In: Schubiger P A, Lehmann L, Friebe M (ed) PET Chemistry: The Driving Force in Molecular Imaging. Ernst Schering Research Foundation Workshop 62 pp 289–316
Cai L, Lu S, Pike VW (2008) Chemistry with [18F]fluoride ion. Eur J Org Chem 17:2853–2870
Roeda D, Dollé F (2010) Aliphatic nucleophilic radiofluorination. Curr Radiopharm 3:81–108
Attiná M, Cacace F, Wolf AP (1983) Displacement of a nitro-group by [18F]fluoride ion. A new route to aryl fluorides of high specific activity. J Chem Soc, Chem Commun 3:108–109
Lu S, Lepore SD, Song YL, Mondal D, Cohn PC, Bhunia AK, Pike VW (2009) Nucleophile assisting leaving groups: a strategy for aliphatic 18F-fluorination. J Org Chem 74:5290–5296
Richarz R, Krapf P, Zarrad F, Urusova EA, Neumaier B, Zlatopolskiy BD (2014) Neither azeotropic drying, nor base nor other additives: a minimalist approach to 18F-labeling. Org Biomol Chem 12:8094–8099
Zischler J, Krapf P, Richarz R, Zlatopolskiy BD, Neumaier B (2016) Automated synthesis of 4-[18F]fluoroanisole, [18F]DAA1106 and 4-[18F]FPhe using Cu-mediated radiofluorination under “minimalist” conditions. Appl Rad Isot 115:133–137
Kim DW, Ahn D-S, Oh Y-H, Lee S, Kil HS, Oh SJ, Lee SJ, Kim JS, Ryu JS, Moon DH, Chi DY (2006) A new class of SN2 reactions catalyzed by protic solvents: facile fluorination for isotopic labeling of diagnostic molecules. J Am Chem Soc 128:16394–16397
Kim DW, Jeong Lim ST, Sohn M-H, Katzenellenbogen JA, Chi DY (2008) Facile nucleophilic fluorination reactions using tert-alcohols as a reaction medium: significantly enhanced reactivity of alkali metal fluorides and improved selectivity. J Org Chem 73:957–962
Pfeifer L, Engle KM, Pidgeon GW, Sparkes HA, Thompson AL, Brown JM, Gouverneur V (2016) Hydrogen-bonded homoleptic fluoride-diarylurea complexes: structure, reactivity, and coordinating power. J Am Chem Soc 138:13314–13325
He P, Haswell SJ, Pamme N, Archibald SJ (2014) Advances in processes for PET radiotracer synthesis: separation of [18F]fluoride from enriched [18O]water. Appl Rad Isot 91:64–70
Pascali G, Matesic L, Collier TL, Wyatt N, Fraser BH, Pham TQ, Salvadori PA, Greguric I (2014) Optimization of nucleophilic 18F radiofluorinations using a microfluidic reaction approach. Nat Protoc 9:2017–2029
De Leonardis F, Pascali G, Salvadori PA, Watts P, Pamme N (2011) On-chip pre-concentration and complexation of [18F]fluoride ions via regenerable anion exchange particles for radiochemical synthesis of Positron Emission Tomography tracers. J Chromatogr A 1218:4714–4719
Lee SJ, Oh SJ, Chi DY, Moon DH, Ryu JS (2012) High yielding [18F]fluorination method by fine control of the base. Bull Korean Chem Soc 33:2177–2180
Seo JW, Lee BS, Lee SJ, Oh SJ, Chi DY (2011) Fast and easy drying method for the preparation of activated [18F]fluoride using polymer cartridge. Bull Korean Chem Soc 32:71–76
Mossine AV, Brooks AF, Ichiishi N, Makaravage KJ, Sanford MS, Scott PJH (2017) Development of customized [18F]fluoride elution techniques for the enhancement of copper-mediated late-stage radiofluorination. Sci Rep 7:233
Iwata R, Pascali C, Terasaki K, Ishikawa Y, Furumoto S, Yanai K (2017) Minimization of the amount of Kryptofix 222 - KHCO3 for applications to microscale 18F-radiolabeling. Appl Rad Isot 125:113–118
Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilbourn MR (1990) Routine production of 2-deoxy-2-[18F]fluoro-d-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Nucl Med Biol 17:273–279
Mathiessen B, Zhuravlev F (2013) Automated solid-phase radiofluorination using polymer-supported phosphazenes. Molecules 18:10531–10547
Sergeev ME, Morgia F, Lazari M, Wang C, van Dam RM (2015) Titania-catalyzed radiofluorination of tosylated precursors in highly aqueous medium. J Am Chem Soc 137:5686–5694
Wessmann SH, Henriksen G, Wester HJ (2012) Cryptate mediated nucleophilic 18F-fluorination without azeotropic drying. NuklearMedizin 51:1–8
Kostikov AP, Chin J, Orchowski K, Niedermoser S, Kovacevic MM, Aliaga A, Jurkschat K, Wängler B, Wängler C, Wester HJ, Schirrmacher R (2012) Oxalic acid supported Si-18F-radiofluorination: one-step radiosynthesis of N-succinimidyl 3-(di-tert-butyl [18F]fluorosilyl) benzoate ([18F]SiFB) for protein labeling. Bioconjugate Chem 23:106–114
Mathiessen B, Jensen M, Zhuravlev F (2011) [18F]Fluoride recovery via gaseous [18F]HF. J Label Compd Radiopharm 54:816–818
Lemaire CF, Aerts JJ, Voccia S, Libert LC, Mercier F, Goblet D, Plenevaux AR, Luxen AJ (2010) Fast production of highly reactive No-Carrier-Added [18F]fluoride for the labeling of radiopharmaceuticals. Ang Chem Int Ed 49:3161–3164
Friebe M, Graham K, Berndt M, Schmitt-Willich H (2010) Process for production of radiopharmaceuticals. Patent WO2010/003548 A1
Aerts J, Voccia S, Lemaire C, Giacomelli F, Goblet D, Thonon D, Plenevaux A, Warnock G, Luxen A (2010) Fast production of highly concentrated reactive [18F]fluoride for aliphatic and aromatic nucleophilic radiolabelling. Tetrahedron Lett 51:64–66
Brichard L, Aigbirhio F (2014) An Efficient method for enhancing the reactivity and flexibility of [18F]fluoride towards nucleophilic substitution using tetraethylammonium bicarbonate. Eur J Org Chem 2014:6145–6149
Kim DW, Choe YS, Chi DY (2003) A new nucleophilic fluorine-18 labeling method for aliphatic mesylates: reaction in ionic liquids shows tolerance for water. Nucl Med Biol 30:345–350
Lindner S, Rensch C, Neubaur S, Neumeier M, Salvamoser R, Samper V, Bartenstein P (2016) Azeotropic drying free [18F]FDG synthesis and its application to a lab-on-chip platform. Chem Commun 52:729–732
Kniess T, Laube M, Steinbach J (2017) “Hydrous 18F-fluoroethylation”—Leaving off the azeotropic drying. Appl Rad Isot 127:260–268
Chun J-H, Telu S, Lu S, Pike VW (2013) Radiofluorination of diaryliodonium tosylates under aqueous-organic and cryptand-free conditions. Org Biomol Chem 11:5094–5099
Klenner MA, Pascali G, Zhang B, Sia TR, Spare LK, Krause-Heuer AM, Aldrich-Wright JR, Greguric I, Guastella AJ, Massi M, Fraser BH (2017) A fluorine-18 radiolabeling method enabled by rhenium(I) complexation circumvents the requirement of anhydrous conditions. Chem Eur J 23:6499–6503
Zischler J, Kolks N, Modemann D, Neumaier B, Zlatopolskiy BD (2017) Alcohol-enhanced Cu-mediated radiofluorination. Chem Eur J 23:3251–3256
Hamacher K, Hirschfelder T, Coenen HH (2002) Electrochemical cell for separation of [18F]fluoride from irradiated 18O-water and subsequent no carrier added nucleophilic fluorination. Appl Rad Isot 56:519–523
Kügler F, Roehrens D, Stumpf M, Drerup C, Ermert J, Hamacher K, Coenen HH (2014) Optimizing the transfer of [18F]fluoride from aqueous to organic solvents by electrodeposition using carbon electrodes. Appl Rad Isot 91:1–7
Sadeghi S, Liang V, Cheung S, Woo S, Wu C, Ly J, Deng Y, Eddings M, van Dam RM (2013) Reusable electrochemical cell for rapid separation of [18F]fluoride from [18O]water for flow-through synthesis of 18F-labeled tracers. Appl Rad Isot 75:85–94
Saiki H, Iwata R, Nakanishi H, Wong R, Ishikawa Y, Furumoto S, Yamahara R, Sakamoto K, Ozeki E (2010) Electrochemical concentration of no-carrier-added [18F]fluoride from [18O]water in a disposable microfluidic cell for radiosynthesis of 18F-labeled radiopharmaceuticals. Appl Rad Isot 68:1703–1708
Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, Stöcklin G (1999) Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-l-tyrosine for tumor imaging. J Nucl Med 40:205–212
Zuhayra M, Alfteimi A, Forstner CV, Lützen U, Meller B, Henze E (2009) New approach for the synthesis of [18F]fluoroethyltyrosine for cancer imaging: simple, fast, and high yielding automated synthesis. Bioorg Med Chem 17:7441–7448
Mueller D, Klette I, Kalb F, Baum RP (2011) Synthesis of O-(2-[18F]fluoroethyl)-l-tyrosine based on a cartridge purification method. Nucl Med Biol 38:653–658
Langen K-J, Hamacher K, Weckesser M, Floeth F, Stoffels G, Bauer D, Coenen HH, Pauleit D (2006) O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 33:287–294
Bourdier T, Greguric I, Roselt P, Jackson T, Faragalla J, Katsifis A (2011) Fully automated one-pot radiosynthesis of O-(2-[18F]fluoroethyl)-l-tyrosine on the TracerLab FXFN module. Nucl Med Biol 38:645–651
Fedorova O, Kuznetsova O, Stepanova M, Maleev V, Belokon Y, Wester H-J, Krasikova R (2014) A facile direct nucleophilic synthesis of O-(2-[18F]fluoroethyl)-l-tyrosine ([18F]FET) without HPLC purification. J Radioanal Nucl Chem 301:505–512
Topley AC, Isoni V, Logothetis TA, Wynn D, Wadsworth H, Gibson AMR, Khan I, Wells NJ, Perrio C, Brown RCD (2013) A Resin-Linker-Vector Approach to Radiopharmaceuticals Containing 18F: application in the Synthesis of O-(2-[18F]Fluoroethyl)-L-tyrosine. Chem Eur J 19:1720–1725
Been LB, Suurmeijer AJH, Cobben DCP, Jager PL, Hoekstra HJ, Elsinga PH (2004) [18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging 31:1659–1672
Wilson IK, Chatterjee S, Wolf W (1991) Synthesis of 3′-fluoro-3′-deoxythymidine and studies of its 18F-radiolabeling, as a tracer for the noninvasive monitoring of the biodistribution of drugs against AIDS. J Fluor Chem 55:283–289
Grierson JR, Shields AF, Eary JF (1997) Development of a radiosynthesis for 3′-[18F]fluoro-3′-deoxy-nucleosides. J Label Compd Radiopharm 40:60–62
Alauddin MM (2013) Nucleoside-based probes for imaging tumor proliferation using positron emission tomography. J Label Compd Radiopharm 56:237–243
Meyer J-P, Probst KC, Westwell AD (2014) Radiochemical synthesis of 2′-[18F]-labelled and 3′-[18F]-labelled nucleosides for positron emission tomography imaging. J Label Compd Radiopharm 57:333–337
Machulla H-J, Blocher A, Kuntzsch M, Piert M, Wei R, Grierson JR (2000) Simplified labeling approach for synthesizing 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT). J Radioanal Nucl Chem 243:843–846
Wodarski C, Eisenbarth J, Weber K, Henze M, Haberkorn U, Eisenhut M (2000) Synthesis of 3′-deoxy-3′-[18F]fluoro-thymidine with 2,3′-anhydro-5′-O-(4,4′-dimethoxytrityl)-thymidine. J Label Compd Radiopharm 43:1211–1218
Grierson JR, Shields AF (2000) Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivo. Nucl Med Biol 27:143–156
Reischl G, Blocher A, Wei RQ, Ehrlichmann W, Kuntzch M, Solbach C, Dohmen BM, Machulla HJ (2006) Simplified, automated synthesis of 3′[18F]fluoro-3′-deoxy-thymidine ([18F]FLT) and simple method for a metabolite analysis in plasma. Radiochim Acta 94:447–451
Yun M, Oh SJ, Ha H-J, Ryu JS, Moon DH (2003) High radiochemical yield synthesis of 3′-deoxy-3′-[18F]fluorothymidine using (5′-O-dimethoxytrityl-2′-deoxy-3′-O-nosyl-β-D-threo pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor. Nucl Med Biol 30:151–157
Martin SJ, Eisenbarth JA, Wagner-Utermann U, Mier W, Henze M, Pritzkow H, Haberkorn U, Eisenhut M (2002) A new precursor for the radiosynthesis of [18F]FLT. Nucl Med Biol 29:263–273
Oh SJ, Mosdzianowski C, Chi DY, Kim JY, Kang SH, Ryu JS, Yeo JS, Moon DH (2004) Fully automated synthesis system of 3′-deoxy-3′-[18F]fluorothymidine. Nucl Med Biol 31:803–809
Teng B, Wang S, Fu Z, Dang Y, Wu Z, Liu L (2006) Semiautomatic synthesis of 3′-deoxy-3′-[18F]fluorothymidine using three precursors. Appl Rad Isot 64:187–193
Suehiro M, Vallabhajosula S, Goldsmith SJ, Ballon DJ (2007) Investigation of the role of the base in the synthesis of [18F]FLT. Appl Rad Isot 65:1350–1358
Marchand P, Ouadi A, Pellicioli M, Schuler J, Laquerriere P, Boisson F, Brasse D (2016) Automated and efficient radiosynthesis of [18F]FLT using a low amount of precursor. Nucl Med Biol 43:520–527
Pascali C, Bogni A, Fugazza L, Cucchi C, Crispu O, Laera L, Iwata R, Maiocchi G, Crippa F, Bombardieri E (2012) Simple preparation and purification of ethanol-free solutions of 3′-deoxy-3′-[18F]fluorothymidine by means of disposable solid-phase extraction cartridges. Nucl Med Biol 39:540–550
Cheung Y-Y, Nickels ML, McKinley ET, Buck JR, Manning HC (2015) High-yielding, automated production of 3′-deoxy-3′-[18F]fluorothymidine using a modified Bioscan Coincidence FDG reaction module. Appl Rad Isot 97:47–51
Lee SJ, Oh SJ, Chi DY, Kil HS, Kim EN, Ryu JS, Moon DH (2007) Simple and highly efficient synthesis of 3′-deoxy-3′-[18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solvent. Eur J Nucl Med Mol Imaging 34:1406–1409
Liu W, Huang X, Placzek MS, Krska SW, McQuade P, Hooker JM, Groves JT (2018) Site-selective 18F fluorination of unactivated C–H bonds mediated by a manganese porphyrin. Chem Sci 9:1168–1172
Coenen HH, Ermert J (2010) Direct nucleophilic 18F-fluorination of electron rich arenes: present limits of no-carrier-added reactions. Curr Radiopharm 3:163–173
Elmenhorst D, Kroll T, Matusch A, Bauer A (2012) Sleep deprivation increases cerebral serotonin 2A receptor binding in humans. Sleep 35:1615–1623
Quednow BB, Treyer V, Hasler F, Dörig N, Wyss MT, Burger C, Rentsch KM, Westera G, Schubiger PA, Buck A, Vollenweider FX (2012) Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography. NeuroImage 59:3922–3932
Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L (1991) Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med 32:2266–2272
Hamacher K, Coenen HH (2006) No-carrier-added nucleophilic 18F-labelling in an electrochemical cell exemplified by the routine production of [18F]altanserin. Appl Rad Isot 64:989–994
Ermert J, Coenen HH (2010) Nucleophilic 18F-fluorination of complex molecules in activated carbocyclic aromatic position. Curr Radiopharm 3:109–126
Hasler F, Kuznetsova OF, Krasikova RN, Cservenyak T, Quednow BB, Vollenweider FX, Ametamey SM, Westera G (2009) GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies. Appl Rad Isot 67:598–601
Hayashi K, Furutsuka K, Ito T, Muto M, Aki H, Fukumura T, Suzuki K (2012) Fully automated synthesis and purification of 4-(2′-methoxyphenyl)-1-[2′-(N-2″-pyridinyl)-p-[18F]fluorobenzamido]ethylpiperazine. J Label Compd Radiopharm 55:120–124
Le Bars D, Lemaire C, Ginovart N, Plenevaux A, Aerts J, Brihaye C, Hassoun W, Leviel V, Mekhsian P, Weissmann D, Pujol JF, Luxen A, Comar D (1998) High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol 25:343–350
Broggini G, Orlandi M, Turconi A, Zoni C (2003) A new synthesis of flumazenil suitable for fluorine-18 labeling. Org Prep Proced Int 35:609–613
Nasirzadeh M, Vaulina DD, Kuznetsova OF, Gomzina NA (2016) A novel approach to the synthesis of [18F]flumazenil, a radioligand for PET imaging of central benzodiazepine receptors. Russ Chem Bull 65:794–800
Ryzhikov NN, Seneca N, Krasikova RN, Gomzina NA, Shchukin E, Fedorova OS, Vassiliev DA, Gulyás B, Hall H, Savic I, Halldin C (2005) Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography. Nucl Med Biol 32:109–116
Dollé F (2005) Fluorine-18-labelled fluoropyridines: advances in radiopharmaceutical design. Curr Pharm Des 11:3221–3235
Dollé F (2007) [18F]Fluoropyridines: From conventional radiotracers to the labeling of macromolecules such as proteins and oligonucleotides In: Schubiger P A, Lehmann L, Friebe M (ed) PET Chemistry: The Driving Force in Molecular Imaging. Ernst Schering Research Foundation Workshop 62 pp 113–157
Ding YS, Liang F, Fowler JS, Kuhar MJ, Carroll FI (1997) Synthesis of [18F]norchlorofluoroepibatidine and its N-methyl derivative: new PET ligands for mapping nicotinic acetylcholine receptors. J Label Compd Radiopharm 39:827–832
Dollé F, Valette H, Bottlaender M, Hinnen F, Vaufrey F, Guenther I, Crouzel C (1998) Synthesis of 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors. J Label Compd Radiopharm 41:451–463
Ding YS, Liu N, Wang T, Marecek J, Garza V, Ojima I, Fowler JS (2000) Synthesis and evaluation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. Nucl Med Biol 27:381–389
Brust P, Patt JT, Deuther-Conrad W, Becker G, Patt M, Schildan A, Sorger D, Kendziorra K, Meyer P, Steinbach J, Sabri O (2008) In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine. Synapse 62:205–218
Easwaramoortry B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J (2007) Effect of acetylcholinesterase inhibitors on the binding of nicotinic α4β2 receptor PET radiotracer, 18F-nifene: a measure of acetylcholine competition. Synapse 61:29–36
Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J (2006) Nicotinic α4β2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol 33:295–304
Ermert J, Coenen HH (2010) No-carrier-added [18F]fluorobenzene derivatives as intermediates for built-up radiosyntheses. Curr Radiopharm 3:127–160
Lemaire C, Guillaume M, Cantineau R, Christiaens L (1990) No-Carrier-Added Regioselective Preparation of 6-[18F]Fluoro-L-Dopa. J Nucl Med 31:1247–1251
Lemaire C, Damhaut P, Plenevaux A, Comar D (1994) Enantioselective synthesis of 6-[18F]fluoro-L-dopa from no- carrier-added fluorine-18-fluoride. J Nucl Med 35:1996–2002
Lemaire C, Gillet S, Guillouet S, Plenevaux A, Aerts J, Luxen A (2004) Highly enantioselective synthesis of no-carrier-added 6-[18F]fluoro-L-dopa by chiral phase-transfer alkylation. Eur J Org Chem 13:2899–2904
Libert LC, Franci X, Plenevaux AR, Ooi T, Maruoka K, Luxen AJ, Lemaire CF (2013) Production at the curie level of no-carrier-added 6-18F-fluoro- l-dopa. J Nucl Med 54:1154–1161
Wagner FM, Ermert J, Coenen HH (2009) Three-Step, “One-Pot” Radiosynthesis of 6-Fluoro-3,4-Dihydroxy-l-Phenylalanine by Isotopic Exchange. J Nucl Med 50:1724–1729
Castillo Meleán J, Ermert J, Coenen HH (2011) Enantiospecific synthesis of 2-[18F]fluoro-l-phenylalanine and 2-[18F]fluoro-l-tyrosine by isotopic exchange. Org Biomol Chem 9:765–769
Castillo Meleán J, Humpert S, Ermert J, Coenen HH (2015) Stereoselective radiosynthesis of L- and D-3-[18F]fluoro-α-methyltyrosine. J Fluor Chem 178:202–207
Martin R, Baumgart D, Hubner S, Juttler S, Saul S, Clausnitzer A, Mollitor J, Smits R, Höpping A, Müller M (2013) Automated nucleophilic one-pot synthesis of 18F-L-DOPA with high specific activity using the GE TRACERlab MXFDG. J Label Compd Radiopharm 56:S126–S126
Pretze M, Franck D, Kunkel F, Foßhag E, Wängler C, Wängler B (2017) Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-L-DOPA. Nucl Med Biol 45:35–42
Pike VW, Aigbirhio FI (1995) Reactions of cyclotron-produced [18F]fluoride with diaryliodonium salts—A novel single-step route to no-carrier-added [18]fluoroarenes. J Chem Soc, Chem Commun 21:2215–2216
Pike VW (2018) Hypervalent aryliodine compounds as precursors for radiofluorination. J Label Compd Radiopharm 61:196–227
Mu L, Fischer CR, Holland JP, Becaud J, Schubiger PA, Schibli R, Ametamey SM, Graham K, Stellfeld T, Dinkelborg LM, Lehmann L (2012) 18F-radiolabeling of aromatic compounds using triarylsulfonium salts. Eur J Org Chem 5:889–892
Ermert J, Hocke C, Ludwig T, Gail R, Coenen H (2004) Comparison of pathways to the versatile synthon of no-carrier-added 1-bromo-4-[18F]fluorobenzene. J Label Compd Radiopharm 47:429–441
Wüst FR, Kniess T (2003) Synthesis of 4-[18F]fluoroiodobenzene and its application in Sonogashira cross-coupling reactions. J Label Compd Radiopharm 46:699–713
Ross TL, Ermert J, Hocke C, Coenen HH (2007) Nucleophilic 18F-fluorination of heteroaromatic iodonium salts with no-carrier-added [18F]fluoride. J Am Chem Soc 129:8018–8025
Way J, Bouvet V, Wuest F (2013) Synthesis of 4-[18F]fluorohalobenzenes and Palladium-mediated cross-coupling reactions for the synthesis of 18F-labeled radiotracers. Curr Org Chem 17:2138–2152
Way JD, Wuest F (2014) Automated radiosynthesis of no-carrier-added 4-[18F]fluoroiodobenzene: a versatile building block in 18F radiochemistry. J Label Compd Radiopharm 57:104–109
Yoshimura A, Zhdankin VV (2016) Advances in synthetic applications of hypervalent iodine compounds. Chem Rev 116:3328–3435
Wang B, Qin L, Neumann KD, Uppaluri S, Cerny RL, DiMagno SG (2010) Improved arene fluorination methodology for I(III) salts. Org Lett 12:3352–3355
Hu B, Va̅vere AL, Neumann KD, Shulkin BL, DiMagno SG, Snyder SE (2015) A practical, automated synthesis of meta-[18F]fluorobenzylguanidine for clinical use. ACS Chem Neurosci 6:1870–1879
Linstad EJ, Vavere AL, Hu B, Kempinger JJ, Snyder SE, DiMagno SG (2017) Thermolysis and radiofluorination of diaryliodonium salts derived from anilines. Org Biomol Chem 15:2246–2252
Petersen IN, Villadsen J, Hansen HD, Madsen J, Jensen AA, Gillings N, Lehel S, Herth MM, Knudsen GM, Kristensen JL (2017) 18F-Labelling of electron rich iodonium ylides: application to the radiosynthesis of potential 5-HT2A receptor PET ligands. Org Biomol Chem 15:4351–4358
Cardinale J, Ermert J, Humpert S, Coenen HH (2014) Iodonium ylides for one-step, no-carrier-added radiofluorination of electron rich arenes, exemplified with 4-(([18F]fluorophenoxy)-phenylmethyl) piperidine NET and SERT ligands. RSC Adv 4:17293–17299
Rotstein BH, Stephenson NA, Vasdev N, Liang SH (2014) Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics. Nat Commun 5:4365
Rotstein BH, Wang L, Liu RY, Patteson J, Kwan EE, Vasdev N, Liang SH (2016) Mechanistic studies and radiofluorination of structurally diverse pharmaceuticals with spirocyclic iodonium(III) ylides. Chem Sci 7:4407–4417
Ichiishi N, Brooks AF, Topczewski JJ, Rodnick ME, Sanford MS, Scott PJH (2014) Copper-catalyzed [18F]fluorination of (Mesityl)(aryl)iodonium salts. Org Lett 16:3224–3227
McCammant MS, Thompson S, Brooks AF, Krska SW, Scott PJH, Sanford MS (2017) Cu-mediated C–H 18F-fluorination of electron-rich (hetero)arenes. Org Lett 19:3939–3942
Stephenson NA, Holland JP, Kassenbrock A, Yokell DL, Livni E, Liang SH, Vasdev N (2015) Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use. J Nucl Med 56:489–492
Zlatopolskiy BD, Zischler J, Krapf P, Zarrad F, Urusova EA, Kordys E, Endepols H, Neumaier B (2015) Copper-mediated aromatic radiofluorination revisited: efficient production of PET tracers on a preparative scale. Chem Eur J 21:5972–5979
Moon B, Park J, Lee H, Lee B, Kim S (2014) Routine production of [18F]flumazenil from iodonium tosylate using a sample pretreatment method: a 2.5-year production report. Mol Imaging Biol 16:619–625
Warnier C, Lemaire C, Becker G, Zaragoza G, Giacomelli F, Aerts J, Otabashi M, Bahri MA, Mercier J, Plenevaux A, Luxen A (2016) Enabling efficient positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) with a robust and one-step radiosynthesis of a highly potent 18F-labeled ligand ([18F]UCB-H). J Med Chem 59:8955–8966
Beyzavi MH, Mandal D, Strebl MG, Neumann CN, D’Amato EM, Chen J, Hooker JM, Ritter T (2017) 18F-deoxyfluorination of phenols via Ru π-complexes. ACS Cent Sci 3:944–948
Strebl MG, Campbell AJ, Zhao W-N, Schroeder FA, Riley MM, Chindavong PS, Morin TM, Haggarty SJ, Wagner FF, Ritter T, Hooker JM (2017) HDAC6 brain mapping with [18F]bavarostat enabled by a Ru-mediated deoxyfluorination. ACS Cent Sci 3:1006–1014
Narayanam MK, Ma G, Champagne PA, Houk KN, Murphy JM (2017) Synthesis of [18F]fluoroarenes by nucleophilic radiofluorination of N-arylsydnones. Ang Chem Int Ed 56:13006–13010
Cardinale J, Ermert J, Kuegler F, Helfer A, Brandt MR, Coenen HH (2012) Carrier-effect on palladium-catalyzed, nucleophilic 18F-fluorination of aryl triflates. J Label Compd Radiopharm 55:450–453
Lee E, Kamlet AS, Powers DC, Neumann CN, Boursalian GB, Furuya T, Choi DC, Hooker JM, Ritter T (2011) A fluoride-derived electrophilic late-stage fluorination reagent for PET imaging. Science 334:639–642
Lee E, Hooker JM, Ritter T (2012) Nickel-mediated oxidative fluorination for PET with aqueous [18F]fluoride. J Am Chem Soc 134:17456–17458
Zlatopolskiy BD, Zischler J, Urusova EA, Endepols H, Kordys E, Frauendorf H, Mottaghy FM, Neumaier B (2015) A practical one-pot synthesis of positron emission tomography (PET) tracers via nickel-mediated radiofluorination. ChemistryOpen 4:457–462
Hoover AJ, Lazari M, Ren H, Narayanam MK, Murphy JM, van Dam RM, Hooker JM, Ritter T (2016) A transmetalation reaction enables the synthesis of [18F]5-fluorouracil from [18F]fluoride for human PET imaging. Organometallics 35:1008–1014
Tredwell M, Preshlock SM, Taylor NJ, Gruber S, Huiban M, Passchier J, Mercier J, Génicot C, Gouverneur V (2014) A general copper-mediated nucleophilic 18F fluorination of arenes. Ang Chem Int Ed 53:7751–7755
Mossine AV, Brooks AF, Makaravage KJ, Miller JM, Ichiishi N, Sanford MS, Scott PJH (2015) Synthesis of [18F]arenes via the copper-mediated [18F]fluorination of boronic acids. Org Lett 17:5780–5783
Makaravage KJ, Brooks AF, Mossine AV, Sanford MS, Scott PJH (2016) Copper-Mediated Radiofluorination of Arylstannanes with [18F]KF. Org Lett 18:5440–5443
Preshlock S, Calderwood S, Verhoog S, Tredwell M, Huiban M, Hienzsch A, Gruber S, Wilson TC, Taylor NJ, Cailly T, Schedler M, Collier TL, Passchier J, Smits R, Mollitor J, Hoepping A, Mueller M, Genicot C, Mercier J, Gouverneur V (2016) Enhanced copper-mediated 18F-fluorination of aryl boronic esters provides eight radiotracers for PET applications. Chem Commun 52:8361–8364
Zhang Z, Lau J, Kuo H-T, Zhang C, Colpo N, Bénard F, Lin K-S (2017) Synthesis and evaluation of 18F-labeled CJ-042794 for imaging prostanoid EP4 receptor expression in cancer with positron emission tomography. Bioorg Med Chem Lett 27:2094–2098
Tang T, Gill HS, Ogasawara A, Tinianow JN, Vanderbilt AN, Williams S-P, Hatzivassiliou G, White S, Sandoval W, DeMent K, Wong M, Marik J (2017) Preparation and evaluation of L- and D-5-[18F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases. Nucl Med Biol 51:10–17
Giglio BC, Fei H, Wang M, Wang H, He L, Feng H, Wu Z, Lu HZL (2017) Synthesis of 5-[18F]Fluoro-α-methyl tryptophan: new Trp based PET agents. Theranostics 7:1524–1530
Schäfer D, Weiß P, Ermert J, Castillo Meleán J, Zarrad F, Neumaier B (2016) Preparation of no-carrier-added 6-[18F]Fluoro-l-tryptophan via Cu-mediated radiofluorination. Eur J Org Chem 2016:4621–4628
Antuganov D, Zykov M, Timofeeva K, Antuganova Y, Orlovskaya V, Krasikova R (2017) Effect of pyridine addition on the efficiency of copper-mediated radiofluorination of aryl pinacol boronates. ChemistrySelect 2:7909–7912
Zarrad F, Zlatopolskiy B, Krapf P, Zischler J, Neumaier B (2017) A practical method for the preparation of 18F-labeled aromatic amino acids from nucleophilic [18F]fluoride and stannyl precursors for electrophilic radiohalogenation. Molecules 22:2231
Zlatopolskiy BD, Zischler J, Schäfer D, Urusova EA, Guliyev M, Bannykh O, Endepols H, Neumaier B (2018) Discovery of 7-[18F]fluorotryptophan as a novel positron emission tomography (PET) probe for the visualization of tryptophan metabolism in vivo. J Med Chem 61:189–206
Politis M (2014) Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol 10:708–722
Lussey-Lepoutre C, Hindié E, Montravers F, Detour J, Ribeiro MJS, Taïeb D, Imperiale A (2016) The current role of 18F-FDOPA PET for neuroendocrine tumor imaging. Med Nucl 40:20–30
Ermert J, Coenen HH (2013) Methods for 11C- and 18F-labelling of amino acids and derivatives for positron emission tomography imaging. J Label Compd Radiopharm 56:225–236
Edwards R, Wirth T (2015) [18F]6-fluoro-3,4-dihydroxy- l-phenylalanine – recent modern syntheses for an elusive radiotracer. J Label Compd Radiopharm 58:183–187
Forsback S, Eskola O, Haaparanta M, Bergmann J, Solin O (2008) Electrophilic synthesis of 6-[18F]fluoro-L-DOPA using post-target produced [18F]F2. Radiochim Acta 96:845–848
Kuik WJ, Kema IP, Brouwers AH, Zijlma R, Neumann KD, Dierckx RAJO, DiMagno SG, Elsinga PH (2015) In vivo biodistribution of no-carrier-added 6-18F-fluoro-3, 4-dihydroxy-l-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution. J Nucl Med 56:106–112
Kienzle GJ, Reischl G, Machulla HJ (2005) Electrochemical radiofluorination. 3. Direct labeling of phenylalanine derivatives with [18F]fluoride after anodic oxidation. J Label Compd Radiopharm 48:259–273
He Q, Wang Y, Alfeazi I, Sadeghi S (2014) Electrochemical nucleophilic synthesis of di-tert-butyl-(4-[18F]fluoro-1,2-phenylene)-dicarbonate. Appl Rad Isot 92:52–57
He Q, Alfeazi I, Sadeghi S (2014) No-carrier-added electrochemical nucleophilic radiofluorination of aromatics. J Radioanal Nucl Chem 303:1037–1040
Lebedev A, Jiao J, Lee JS, Yang F, Allison N, Herschman H, Sadeghi S (2017) Radiochemistry on electrodes: synthesis of an 18F-labelled and in vivo stable COX-2 inhibitor. PLoS ONE 12:18
Krasikova R (2013) PET radiochemistry automation: state of the art and future trends in 18F-nucleophilic fluorination. Curr Org Chem 17:2097–2107
Anzellotti A, McFarland A, Ferguson D, Olson K (2013) Towards the full automation of QC release tests for [18F]fluoride-labeled radiotracers. Curr Org Chem 17:2153–2158
Shao X, Hoareau R, Hockley BG, Tluczek LJM, Henderson BD, Padgett HC, Scott PJH (2011) Highlighting the versatility of the tracerlab synthesis modules. Part 1: fully automated production of 18F-labelled radiopharmaceuticals using a Tracerlab FXFN. J Label Compd Radiopharm 54:292–307
Iwata R, Ido T, Takahashi T, Monma M (1984) Automated synthesis system for production of 2-deoxy-2-[18F]fluoro-d-glucose with computer control. Int J Appl Rad Isot 35:445–454
Padgett HC, Schmidt DG, Luxen A, Bida GT, Satyamurthy N, Barrio JR (1989) Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. Int J Appl Radiat Isot 40:433–445
Herman H, Flores G, Quinn K, Eddings M, Olma S, Moore MD, Ding H, Bobinski KP, Wang M, Williams D, Wiliams D, Shen CK-F, Phelps ME, van Dam RM (2013) Plug-and-play modules for flexible radiosynthesis. Appl Rad Isot 78:113–124
Blom E, Koziorowski J (2014) Automated synthesis of [18F]FMISO on IBA Synthera((R)). J Radioanal Nucl Chem 299:265–270
Lee SJ, Hyun JS, Oh SJ, Yu KH, Ryu JS (2013) Development of a new precursor-minimizing base control method and its application for the automated synthesis and SPE purification of 18F-fluoromisonidazole (18F-FMISO). J Label Compd Radiopharm 56:731–735
Collins J, Waldmann CM, Drake C, Slavik R, Ha NS, Sergeev M, Lazari M, Shen B, Chin FT, Moore M, Sadeghi S, Phelps ME, Murphy JM, van Dam RM (2017) Production of diverse PET probes with limited resources: 24 18F-labeled compounds prepared with a single radiosynthesizer. Proc Natl Acad Sci 114:11309–11314
von Guggenberg E, Sader JA, Wilson JS, Shahhosseini S, Koslowsky I, Wuest F, Mercer JR (2009) Automated synthesis of an 18F-labelled pyridine-based alkylating agent for high yield oligonucleotide conjugation. Appl Rad Isot 67:1670–1675
Allott L, Da Pieve C, Turton DR, Smith G (2017) A general [18F]AlF radiochemistry procedure on two automated synthesis platforms. React Chem Eng 2:68–74
Ackermann U, Yeoh SD, Sachinidis JI, Poniger SS, Scott AM, Tochon-Danguy HJ (2011) A simplified protocol for the automated production of succinimidyl 4-[18F]fluorobenzoate on an IBA Synthera module. J Label Compd Radiopharm 54:671–673
Sachinidis JI, Poniger S, Tochon-Danguy HJ (2010) Automation for optimised production of fluorine-18-Labelled radiopharmaceuticals. Curr Radiopharm 3:248–253
Lazari M, Collins J, Shen B, Farhoud M, Yeh D, Maraglia B, Chin FT, Nathanson DA, Moore M, van Dam RM (2014) Fully automated production of diverse 18F-labeled PET tracers on the ELIXYS multireactor radiosynthesizer without hardware modification. J Nucl Med Technol 42:203–210
Yao CH, Lin KJ, Weng CC, Hsiao IT, Ting YS, Yen TC, Jan TR, Skovronsky D, Kung MP, Wey SP (2010) GMP-compliant automated synthesis of [18F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain. Appl Rad Isot 68:2293–2297
Liu YJ, Zhu L, Plossl K, Choi SR, Qiao HW, Sun XT, Li S, Zha ZH, Kung HF (2010) Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer’s disease. Nucl Med Biol 37:917–925
Wang HL, Guo XY, Jiang SD, Tang GH (2013) Automated synthesis of [18F]Florbetaben as Alzheimer’s disease imaging agent based on a synthesis module system. Appl Rad Isot 71:41–46
Turton DR, Betts HM, Dutton D, Perkins AC (2015) Automated radiosynthesis of GMP quality [18F]HX4 for PET imaging of hypoxia. Nucl Med Biol 42:494–498
Thomae D, Morley TJ, Hamill T, Carroll VM, Papin C, Twardy NM, Lee HS, Hargreaves R, Baldwin RM, Tamagnan G, Alagille D (2014) Automated one-step radiosynthesis of the CB1 receptor imaging agent [18F]MK-9470. J Label Compd Radiopharm 57:611–614
Cardinale J, Martin R, Remde Y, Schäfer M, Hienzsch A, Hübner S, Zerges A-M, Marx H, Hesse R, Weber K, Smits R, Hoepping A, Müller M, Neels O, Kopka K (2017) Procedures for the GMP-compliant production and quality control of [18F]PSMA-1007: a next generation radiofluorinated tracer for the detection of prostate cancer. Pharmaceuticals 10:77
Rensch C, Jackson A, Lindner S, Salvamoser R, Samper V, Riese S, Bartenstein P, Wängler C, Wängler B (2013) Microfluidics: a groundbreaking technology for PET tracer production? Molecules 18:7930–7956
Pascali G, Salvadori PA (2016) Opportunities and challenges in the utilization of microfluidic technologies to the production of radiopharmaceuticals. Chimica Oggi-Chem Today 34:28–32
Elizarov AM (2009) Microreactors for radiopharmaceutical synthesis. Lab Chip 9:1326–1333
Keng PY, van Dam RM (2015) Digital microfluidics: a new paradigm for radiochemistry. Mol Imaging 14(7290):00030
Miller PW, deMello AJ, Gee AD (2010) Application of microfluidics to the ultra-rapid preparation of fluorine-18 labelled compounds. Curr Radiopharm 3:254–262
Wang MW, Lin WY, Liu K, Masterman-Smith M, Shen CKF (2010) Microfluidics for positron emission tomography probe development. Mol Imaging 9:175–191
Hargrove K, Jones GB (2014) Accelerated labeling methods and syntheses of radiotracers utilizing microfluidic technology. Curr Radiopharm 7:36–48
Lebedev A, Miraghaie R, Kotta K, Ball CE, Zhang J, Buchsbaum MS, Kolb HC, Elizarov A (2013) Batch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer. Lab Chip 13:136–145
Lee C-C, Sui G, Elizarov A, Shu CJ, Shin Y-S, Dooley AN, Huang J, Daridon A, Wyatt P, Stout D, Kolb HC, Witte ON, Satyamurthy N, Heath JR, Phelps ME, Quake SR, Tseng H-R (2005) Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics. Science 310:1793–1796
Wong R, Iwata R, Saiki H, Furumoto S, Ishikawa Y, Ozeki E (2012) Reactivity of electrochemically concentrated anhydrous [18F]fluoride for microfluidic radiosynthesis of 18F-labeled compounds. Appl Rad Isot 70:193–199
Fiel SA, Yang H, Schaffer P, Weng S, Inkster JAH, Wong MCK, Li PCH (2015) Magnetic droplet microfluidics as a platform for the concentration of [18F]fluoride and radiosynthesis of sulfonyl [18F]fluoride. ACS Appl Mater Interfaces 7:12923–12929
Cvetkovic BZ, Lade O, Marra L, Arima V, Rinaldi R, Dittrich PS (2012) Nitrogen supported solvent evaporation using continuous-flow microfluidics. RSC Adv 2:11117–11122
Pascali G, De Simone M, Matesic L, Greguric I, Salvadori PA (2014) Tolerance of water in microfluidic radiofluorinations: a potential methodological shift? J Flow Chem 4:86–91
Pamme N (2007) Continuous flow separations in microfluidic devices. Lab Chip 7:1644–1659
Pascali G, Mazzone G, Saccomanni G, Manera C, Salvadori PA (2010) Microfluidic approach for fast labeling optimization and dose-on-demand implementation. Nucl Med Biol 37:547–555
Tarn MD, Pascali G, De Leonardis F, Watts P, Salvadori PA, Pamme N (2013) Purification of 2-[18F]fluoro-2-deoxy-d-glucose by on-chip solid-phase extraction. J Chromatogr A 1280:117–121
Chao PH, Collins J, Argus JP, Tseng WY, Lee JT, van Dam RM (2017) Automatic concentration and reformulation of PET tracers via microfluidic membrane distillation. Lab Chip 17:1802–1816
Wester HJ, Schoultz BW, Hultsch C, Henriksen G (2009) Fast and repetitive in-capillary production of [18F]FDG. Eur J Nucl Med Mol Imaging 36:653–658
Kimura H, Tomatsu K, Saiki H, Arimitsu K, Ono M, Kawashima H, Iwata R, Nakanishi H, Ozeki E, Kuge Y, Saji H (2016) Continuous-flow synthesis of N-succinimidyl 4-[18F]fluorobenzoate using a single microfluidic chip. PLoS ONE 11:e0159303
Pascali G, Watts P, Salvadori PA (2013) Microfluidics in radiopharmaceutical chemistry. Nucl Med Biol 40:776–787
Rensch C, Lindner S, Salvamoser R, Leidner S, Bold C, Samper V, Taylor D, Baller M, Riese S, Bartenstein P, Wangler C, Wangler B (2014) A solvent resistant lab-on-chip platform for radiochemistry applications. Lab Chip 14:2556–2564
Koag MC, Kim H-K, Kim AS (2014) Efficient microscale synthesis of [18F]-2-fluoro-2-deoxy-d-glucose. Chem Eng J 258:62–68
Gillies JM, Prenant C, Chimon GN, Smethurst GJ, Perrie W, Hamblett I, Dekker B, Zweit J (2006) Microfluidic reactor for the radiosynthesis of PET radiotracers. Appl Rad Isot 64:325–332
Arima V, Pascali G, Lade O, Kretschmer HR, Bernsdorf I, Hammond V, Watts P, De Leonardis F, Tarn MD, Pamme N, Cvetkovic BZ, Dittrich PS, Vasovic N, Duane R, Jaksic A, Zacheo A, Zizzari A, Marra L, Perrone E, Salvadori PA, Rinaldi R (2013) Radiochemistry on chip: towards dose-on-demand synthesis of PET radiopharmaceuticals. Lab Chip 13:2328–2336
Keng PY, Chen SP, Ding HJ, Sadeghi S, Shah GJ, Dooraghi A, Phelps ME, Satyamurthy N, Chatziioannou AF, Kim CJ, van Dama RM (2012) Micro-chemical synthesis of molecular probes on an electronic microfluidic device. Proc Natl Acad Sci USA 109:690–695
Javed MR, Chen S, Lei J, Collins J, Sergeev M, Kim H-K, Kim C-J, van Dam RM, Keng PY (2014) High yield and high specific activity synthesis of [18F]fallypride in a batch microfluidic reactor for micro-PET imaging. Chem Commun 50:1192–1194
Ungersboeck J, Richter S, Collier L, Mitterhauser M, Karanikas G, Lanzenberger R, Dudczak R, Wadsak W (2012) Radiolabeling of [18F]altanserin — a microfluidic approach. Nucl Med Biol 39:1087–1092
Javed MR, Chen S, Kim HK, Wei L, Czernin J, Kim CJ, van Dam RM, Keng PY (2014) Efficient radiosynthesis of 3 ‘-deoxy-3 ‘-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip. J Nucl Med 55:321–328
Koag MC, Kim H-K, Kim AS (2014) Fast and efficient microscale radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine. J Fluor Chem 166:104–109
Yokell DL, Leece AK, Lebedev A, Miraghaie R, Ball CE, Zhang J, Kolb H, Elizarov A, Mahmood U (2012) Microfluidic single vessel production of hypoxia tracer 1H-1-(3-[18F]-fluoro-2-hydroxy-propyl)-2-nitro-imidazole ([18F]-FMISO). Appl Rad Isot 70:2313–2316
Zheng M-Q, Collier L, Bois F, Kelada OJ, Hammond K, Ropchan J, Akula MR, Carlson DJ, Kabalka GW, Huang Y (2015) Synthesis of [18F]FMISO in a flow-through microfluidic reactor: development and clinical application. Nucl Med Biol 42:578–584
Liang SH, Yokell DL, Normandin MD, Rice PA, Jackson RN, Shoup TM, Brady TJ, Fakhri GE, Collier TL, Vasdev N (2014) First human use of a radiopharmaceutical prepared by continuous-flow microfluidic radiofluorination: proof of concept with the tau imaging agent [18F]T807. Mol Imaging 13:1–5
Salvadori AP (2008) Radiopharmaceuticals, drug development and pharmaceutical regulations in Europe. Curr Radiopharm 1:7–11
Ha NS, Sadeghi S, van Dam RM (2017) Recent Progress toward microfluidic quality control testing of radiopharmaceuticals. Micromachines 8:337
Taggart MP, Tarn MD, Esfahani MMN, Schofield DM, Brown NJ, Archibald SJ, Deakin T, Pamme N, Thompson LF (2016) Development of radiodetection systems towards miniaturised quality control of PET and SPECT radiopharmaceuticals. Lab Chip 16:1605–1616
Koziorowski J (2010) A simple method for the quality control of [18F]FDG. Appl Rad Isot 68:1740–1742
Nakao R, Ito T, Yamaguchi M, Suzuki K (2008) Simultaneous analysis of FDG, ClDG and Kryptofix 2.2.2 in [18F]FDG preparation by high-performance liquid chromatography with UV detection. Nucl Med Biol 35:239–244
Mihon M, Tuta CS, Ion AC, Koziorowski J, Niculae D, Lavric V, Draganescu D (2017) Influence of the separation parameters applied for determination of impurities FDG and CLDG. Farmacia 65:153–158
Cheung S, Ly J, Lazari M, Sadeghi S, Keng PY, van Dam RM (2014) The separation and detection of PET tracers via capillary electrophoresis for chemical identity and purity analysis. J Pharm Biomed Anal 94:12–18
Huang Y-Y, Taylor S, Koziorowski J, Chang Y-N, Kao W-H, Tzen K-Y, Shiue C-Y (2016) A two-center study for the quality control of [18F]FDG using FASTlab phosphate cassettes. Ann Nucl Med 30:563–571
Chaly T, Dahl JR (1989) Thin layer chromatographic detection of Kryptofix 2.2.2 in the routine synthesis of [18F]2-fluoro-2-deoxy-d-glucose. Nucl Med Biol 16:385–387
Mock BH, Winkle W, Vavrek MT (1997) A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations. Nucl Med Biol 24:193–195
Scott PJH, Kilbourn MR (2007) Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human use. Appl Rad Isot 65:1359–1362
Rokka J, Grönroos TJ, Viljanen T, Solin O, Haaparanta-Solin M (2017) HPLC and TLC methods for analysis of [18F]FDG and its metabolites from biological samples. J Chromatogr B 1048:140–149
Ferrieri RA, Schlyer DJ, Alexoff DL, Fowler JS, Wolf AP (1993) Direct analysis of Kryptofix 2.2.2 in 18FDG by gas chromatography using a nitrogen-selective detector. Nucl Med Biol 20:367–369
Ma Y, Huang BX, Channing MA, Eckelman WC (2002) Quantification of Kryptofix 2.2.2 in 2-[18F]FDG and other radiopharmaceuticals by LC/MS/MS. Nucl Med Biol 29:125–129
Anzellotti AI, McFarland AR, Olson KF (2013) A rapid and simple colorimetric test for 2,2,2-cryptand (Kryptofix 2.2.2.) in solution. Anal Method 5:4317–4320
Campbell MG, Mercier J, Genicot C, Gouverneur V, Hooker JM, Ritter T (2017) Bridging the gaps in F-18 PET tracer development. Nat Chem 9:1–3
Zhang X, Dunlow R, Blackman BN, Swenson RE (2018) Optimization of 18F-syntheses using 19F-reagents at tracer-level concentrations and LC-MS/MS analysis: improved synthesis of [18F]MDL100907. J Label Compd Radiopharm 61:427–437
Acknowledgements
The authors are grateful to Bernd Neumaier for his interest and support.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Coenen, H.H., Ermert, J. 18F-labelling innovations and their potential for clinical application. Clin Transl Imaging 6, 169–193 (2018). https://doi.org/10.1007/s40336-018-0280-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40336-018-0280-0